Cancer SA ← Back to the full guide
Cancer SA · Primary-Source Scientific Analysis

Sunscreen & Skin Cancer: What the Study Data Actually Shows

A viral claim cites a 292% higher melanoma risk among sunscreen users from a UK Biobank study of 470,000 people. We went to the published paper, extracted the raw data, and examined the methodology. Here's what the numbers say - and what they can't say.

Primary source: Jeremian et al. (2023), Cancer Epidemiology, Biomarkers & Prevention, 32(11), 1599–1607 · PubMed Central full text

The viral claim

"Frequent sunscreen use is directly linked to a staggering 292% HIGHER RISK of multiple skin cancers!"

Attributed to Nicolas Hulscher, MPH (McCullough Foundation). Amplified widely across social media, July 2026.

First: What Was This Study Actually About?

The study's title is: "Gene–Environment Analyses in a UK Biobank Skin Cancer Cohort Identifies Important SNPs in DNA Repair Genes That May Help Prognosticate Disease Risk."

It was a genetics paper. The researchers were looking for DNA repair gene variants (particularly in the FANCA gene) that interact with environmental factors to predict who is more likely to develop skin cancer. Sunscreen use was one of 11 variables they examined - not the study's focus.

472,672
Participants
190
DNA Repair Genes
8,798
SNPs Analysed

Nicolas Hulscher is not an author on this paper. The actual authors are Richie Jeremian, Pingxing Xie, Misha Fotovati, Philippe Lefrançois, and Ivan V. Litvinov - all from McGill University, Montreal.


The Raw Numbers: What the Data Shows

These numbers come directly from Table 1 and Table S2 of the published paper. The relative risk (RR) values cited in the viral post do appear in the data:

Sun Protection UseHealthy ControlsInvasive MelanomaCrude Rate
Never / rarely38,1971470.38%
Sometimes149,3627840.52%
Most of the time162,3171,4000.86%
Always92,9111,4021.49%

The gradient is real. People who reported "always" using sun protection had a crude melanoma rate roughly 4x higher than those who "never/rarely" used it. The reported relative risk values across all cancer types:

Cancer TypeReported RRTranslation
Invasive melanoma3.92292% higher
Melanoma in situ3.58258% higher
Basal cell carcinoma2.40140% higher
Squamous cell carcinoma2.26126% higher

So the 292% number is not fabricated. But here is where the methodology becomes critical - because what these numbers mean depends entirely on how they were calculated.


The Three Methodological Problems

These are not opinions or editorial judgments. They are structural limitations documented in the paper's own methods section.

Problem 1: The analysis is univariate - no confounders controlled

From the paper's methods

"Analysis was performed using the multinom function for each predictor variable."

This is the critical issue. The researchers ran multinomial logistic regression on each variable separately. The sunscreen RR of 3.92 is not adjusted for:

In epidemiology, an unadjusted relative risk from an observational study cannot support a causal claim. This is not a controversial position - it is the foundational rule of observational epidemiology, taught in every MPH programme including the one Hulscher attended.

To illustrate why this matters: the study also found that people with lighter skin and red/blonde hair had higher skin cancer rates. If you ran the same univariate logic, you could claim that being blonde causes cancer. The reason you can't is because blondness is a marker for fair skin and UV sensitivity - it's correlated with cancer but doesn't cause it. The same logic applies to sunscreen use.

Problem 2: The question isn't about sunscreen - it's about sun protection generally

UK Biobank field 2267 - actual question wording

"Do you wear sun protection (e.g. sunscreen lotion, hat) when you spend time outdoors in the summer?"

The variable measures "use of sun/UV protection" - which includes hats, clothing, shade-seeking, and sunscreen. The viral claim specifically says "sunscreen use" causes cancer, but the data doesn't isolate sunscreen from other sun-protective behaviours. Someone who always wears a hat outdoors and someone who always applies SPF 50 are in the same category.

Problem 3: No temporal ordering - reverse causation is uncontrolled

From the paper's limitations

"Behavioral findings are self-reported by individuals, where recall bias can play a significant role, and do not account for changes in behavior before and after disease diagnosis."

The UK Biobank questionnaire was administered at a single point in time. A person diagnosed with skin cancer in 2015 who then started using sunscreen religiously appears in the data as both "frequent sun protection user" and "skin cancer patient." The cancer came first - the protection was a response to it, not a cause of it.

The study makes no attempt to exclude people diagnosed before enrollment or to establish whether sun protection use preceded or followed diagnosis.


What the Study's Own Authors Wrote

The authors were aware of the paradox in their data. This is what they wrote in the published paper - not in a press release, not in a tweet, but in the peer-reviewed text itself:

"This paradoxical finding was the increasing risk of skin cancers with increased sunscreen use, which we posit can be explained by greater exposure to UV light and/or a lack of reapplication of sunscreen throughout the day, or due to increased use of sun protection following skin cancer diagnosis." - Jeremian et al., Cancer Epidemiology, Biomarkers & Prevention, 2023

Their conclusion about the finding:

"These findings demonstrate the importance of adequate and frequent sunscreen use and minimisation of exposure to UV light." - Jeremian et al., same paper

The researchers saw the correlation, recognised it as a known confounding pattern, and explicitly concluded that the data supports more sunscreen use - not less.


What Would Actually Prove Sunscreen Causes Cancer?

To make a causal claim, you need one of two things:

What this study did

Observational, univariate. Looked at existing data, analysed each variable separately, found correlations.

Cannot determine cause. Can only say "these things appear together."

Equivalent to noticing that hospitals have more sick people than gyms and concluding hospitals make people sick.

What would be needed

Randomised controlled trial or at minimum a multivariate adjusted analysis controlling for sun exposure, skin type, prior diagnosis, and outdoor time.

Only an RCT can establish cause by balancing all confounders - known and unknown - between groups.

An RCT on sunscreen and melanoma does exist

The Nambour trial (Green et al., 2011) is the only randomised controlled trial ever conducted on sunscreen and melanoma. In 1992, 1,621 Australians were randomly assigned to either daily sunscreen use (free, unlimited SPF 16 supplied) or discretionary use (their own choice).

After 15 years of follow-up:

Nambour RCT results - Journal of Clinical Oncology, 2011
Daily SunscreenDiscretionary Use
Total new melanomas1122
Invasive melanomas311

Because participants were randomised, confounders were balanced between groups. The result: daily sunscreen users developed 50% fewer melanomas and 73% fewer invasive melanomas. This is the gold-standard evidence that the UK Biobank observational correlation cannot override.


Who Made This Claim?

About Nicolas Hulscher

BSc, Oakland University (2020). MPH with epidemiology specialisation, University of Michigan (2024). Administrator at the McCullough Foundation, Dallas. Not an author on the UK Biobank study he cites.

He extracted unadjusted correlation statistics from another team's genetics paper, omitted the authors' own explanation and conclusions, and presented the numbers as proof of causation - a conclusion the study's methodology cannot support and its authors explicitly reject.


Summary: What the Data Says and Doesn't Say

This is the detailed data appendix. The main guide covers what it means for you - including which sunscreen ingredients are worth avoiding and how to choose the least harmful product.

Read the full sunscreen guide

Primary Sources

  1. Jeremian, R., Xie, P., Fotovati, M., Lefrançois, P., & Litvinov, I.V. (2023). "Gene–Environment Analyses in a UK Biobank Skin Cancer Cohort Identifies Important SNPs in DNA Repair Genes That May Help Prognosticate Disease Risk." Cancer Epidemiology, Biomarkers & Prevention, 32(11), 1599–1607. PMC10840669
  2. Green, A.C., Williams, G.M., Logan, V., & Strutton, G.M. (2011). "Reduced Melanoma After Regular Sunscreen Use: Randomized Trial Follow-Up." Journal of Clinical Oncology, 29(3), 257–263. JCO.2010.28.7078
  3. UK Biobank Data Field 2267: "Use of sun/uv protection." biobank.ctsu.ox.ac.uk

Published by Cancer SA - Integrative Oncology & Medicine, Centurion, South Africa. This analysis is for educational purposes and does not constitute medical advice. It is based entirely on the published, peer-reviewed source material cited above. ← Return to the full guide